1.Research Progress in Chinese Medicine Thladiantha Dubia Bunge
Lishu WANG ; Lele YUE ; Dongyan CHENG ; Chaonan WANG
China Pharmacist 2016;19(3):574-578
Thladiantha dubia Bunge is a traditional Chinese medicine in Manzu region applied in the treatment of pain in waist and leg, or strain in lumbar without adverse reaction. By referring to the relative literatures on Thladiantha dubia Bunge from home and abroad, the study progress in the chemical constituents and pharmacological actions of Thladiantha dubia Bunge in the recent 30 years were reviewed to lay foundation for the reasonable exploitation and utilization of Thladiantha dubia Bunge.
2.Research Progress in Chinese Medicine Ephedrae Radix Et Rhizoma
Lele YUE ; Lishu WANG ; Dongyan CHENG ; Daqing ZHAO
China Pharmacist 2015;(8):1383-1386,1393
Ephedrae Radix Et Rhizoma is a traditional Chinese medicine, and the effect of antiperspirant has been recorded in books on Chinese medicines in all dynasties. By referring the relative literatures on Ephedrae Radix Et Rhizoma from home and abroad, the study progress in the chemical constituents, pharmacological actions and clinical application of Ephedrae Radix Et Rhizoma in the latest 40 years were reviewed to lay foundation for the reasonable exploitation and utilization of Ephedrae Radix Et Rhizoma.
3. Quantitative Electrophysiological Evaluation of the Analgesic Efficacy of Two Lappaconitine Derivatives: A Window into Antinociceptive Drug Mechanisms
Guixiang TENG ; Lele CHEN ; Tao ZHOU ; Ji ZHANG ; Guixiang TENG ; Lele CHEN ; Tao ZHOU ; Ji ZHANG ; Fengrui ZHANG ; Libo ZHANG ; Lupeng YUE ; Fengrui ZHANG ; Libo ZHANG ; Lupeng YUE ; Zhenjiang LI ; Chun ZHANG
Neuroscience Bulletin 2021;37(11):1555-1569
Quantitative evaluation of analgesic efficacy improves understanding of the antinociceptive mechanisms of new analgesics and provides important guidance for their development. Lappaconitine (LA), a potent analgesic drug extracted from the root of natural Aconitum species, has been clinically used for years because of its effective analgesic and non-addictive properties. However, being limited to ethological experiments, previous studies have mainly investigated the analgesic effect of LA at the behavioral level, and the associated antinociceptive mechanisms are still unclear. In this study, electrocorticogram (ECoG) technology was used to investigate the analgesic effects of two homologous derivatives of LA, Lappaconitine hydrobromide (LAH) and Lappaconitine trifluoroacetate (LAF), on Sprague-Dawley rats subjected to nociceptive laser stimuli, and to further explore their antinociceptive mechanisms. We found that both LAH and LAF were effective in reducing pain, as manifested in the remarkable reduction of nocifensive behaviors and laser-evoked potentials (LEPs) amplitudes (N2 and P2 waves, and gamma-band oscillations), and significantly prolonged latencies of the LEP-N2/P2. These changes in LEPs reflect the similar antinociceptive mechanism of LAF and LAH, i.e., inhibition of the fast signaling pathways. In addition, there were no changes in the auditory-evoked potential (AEP-N1 component) before and after LAF or LAH treatment, suggesting that neither drug had a central anesthetic effect. Importantly, compared with LAH, LAF was superior in its effects on the magnitudes of gamma-band oscillations and the resting-state spectra, which may be associated with their differences in the octanol/water partition coefficient, degree of dissociation, toxicity, and glycine receptor regulation. Altogether, jointly applying nociceptive laser stimuli and ECoG recordings in rats, we provide solid neural evidence for the analgesic efficacy and antinociceptive mechanisms of derivatives of LA.
4.Cyasterone inhibits IL-1β-mediated apoptosis and inflammation via the NF-κB and MAPK signaling pathways in rat chondrocytes and ameliorates osteoarthritisin vivo.
Li TENG ; Yue SHEN ; Yuhan QU ; Longfei YANG ; Yuting YANG ; Xi JIAN ; Shengli FAN ; Lele ZHANG ; Qiang FU
Chinese Journal of Natural Medicines (English Ed.) 2023;21(2):99-112
Osteoarthritis is a prevalent global joint disease, which is characterized by inflammatory reaction and cartilage degradation. Cyasterone, a sterone derived from the roots of Cyathula officinalis Kuan, exerts protective effect against several inflammation-related diseases. However, its effect on osteoarthritis remains unclear. The current study was designed to investigate the potential anti-osteoarthritis activity of cyasterone. Primary chondrocytes isolated from rats induced by interleukin (IL)-1β and a rat model stimulated by monosodium iodoacetate (MIA) were used for in vitro and in vivo experiments, respectively. The results of in vitro experiments showed that cyasterone apparently counteracted chondrocyte apoptosis, increased the expression of collagen II and aggrecan, and restrained the production of the inflammatory factors inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5), metalloproteinase-3 (MMP-3), and metalloproteinase-13 (MMP-13) induced by IL-1β in chondrocytes. Furthermore, cyasterone ameliorated the inflammation and degenerative progression of osteoarthritis potentially by regulating the nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways. For in vivo experiments, cyasterone significantly alleviated the inflammatory response and cartilage destruction of rats induced by monosodium iodoacetate, where dexamethasone was used as the positive control. Overall, this study laid a theoretical foundation for developing cyasterone as an effective agent for the alleviation of osteoarthritis.
Animals
;
Rats
;
Chondrocytes
;
NF-kappa B
;
Iodoacetic Acid
;
Inflammation
;
MAP Kinase Signaling System
;
Apoptosis
5.Quantitative Electrophysiological Evaluation of the Analgesic Efficacy of Two Lappaconitine Derivatives: A Window into Antinociceptive Drug Mechanisms.
Guixiang TENG ; Fengrui ZHANG ; Zhenjiang LI ; Chun ZHANG ; Libo ZHANG ; Lele CHEN ; Tao ZHOU ; Lupeng YUE ; Ji ZHANG
Neuroscience Bulletin 2021;37(11):1555-1569
Quantitative evaluation of analgesic efficacy improves understanding of the antinociceptive mechanisms of new analgesics and provides important guidance for their development. Lappaconitine (LA), a potent analgesic drug extracted from the root of natural Aconitum species, has been clinically used for years because of its effective analgesic and non-addictive properties. However, being limited to ethological experiments, previous studies have mainly investigated the analgesic effect of LA at the behavioral level, and the associated antinociceptive mechanisms are still unclear. In this study, electrocorticogram (ECoG) technology was used to investigate the analgesic effects of two homologous derivatives of LA, Lappaconitine hydrobromide (LAH) and Lappaconitine trifluoroacetate (LAF), on Sprague-Dawley rats subjected to nociceptive laser stimuli, and to further explore their antinociceptive mechanisms. We found that both LAH and LAF were effective in reducing pain, as manifested in the remarkable reduction of nocifensive behaviors and laser-evoked potentials (LEPs) amplitudes (N2 and P2 waves, and gamma-band oscillations), and significantly prolonged latencies of the LEP-N2/P2. These changes in LEPs reflect the similar antinociceptive mechanism of LAF and LAH, i.e., inhibition of the fast signaling pathways. In addition, there were no changes in the auditory-evoked potential (AEP-N1 component) before and after LAF or LAH treatment, suggesting that neither drug had a central anesthetic effect. Importantly, compared with LAH, LAF was superior in its effects on the magnitudes of gamma-band oscillations and the resting-state spectra, which may be associated with their differences in the octanol/water partition coefficient, degree of dissociation, toxicity, and glycine receptor regulation. Altogether, jointly applying nociceptive laser stimuli and ECoG recordings in rats, we provide solid neural evidence for the analgesic efficacy and antinociceptive mechanisms of derivatives of LA.
Aconitine/pharmacology*
;
Analgesics/pharmacology*
;
Animals
;
Pharmaceutical Preparations
;
Rats
;
Rats, Sprague-Dawley